Associations between interleukin-10, -12, and - 18 and periodontal health and disease: a cross-sectional study
- PMID: 39080003
- PMCID: PMC11289060
- DOI: 10.1007/s00784-024-05843-8
Associations between interleukin-10, -12, and - 18 and periodontal health and disease: a cross-sectional study
Abstract
Objective: We assessed the levels of Interleukin-10 (IL-10), Interleukin-12 (IL-12), and Interleukin-18 (IL-18) in the gingival crevicular fluid (GCF) of subjects with advanced periodontitis (SIII-SIV) compared to healthy controls and evaluated their correlations with clinical measurements.
Methods: This cross-sectional study involved subjects (n = 60) diagnosed with stage III grade B-C (n = 13) to stage IV grade C (n = 17) periodontitis, and periodontally healthy controls (n = 30). Clinical periodontal measurements involved full-mouth. The concentrations of IL-10, IL-12, and IL-18 were determined using enzyme-linked immunosorbent assay (ELISA).
Results: There were no significant differences in IL-12 level and IL-18/IL-10 ratio between the healthy and periodontitis groups (p = 0.413, p = 0.636, respectively). The IL-10 and IL-18 levels were significantly higher in the periodontitis group than in controls (p < 0.001, p < 0.001, respectively). Significant associations were observed between the periodontitis and IL-10 and IL-18 levels (OR = 1.46, %95 CI 1.19-1.795; OR = 1.13, %95 CI 1.059-1.207, respectively) (p < 0.001, p < 0.001, respectively).
Conclusions: There was a correlation between pocket depth and the presence of IL-18 and a strong association between periodontitis and a high level of IL-18. However, there were no direct correlations among the three biomarkers and IL-18/IL-10 ratio, indicating that their roles in periodontal health are complex and multidimensional.
Clinical relevance: Understanding the cytokine dynamics in GCF provides valuable insights into their potential clinical implications for periodontal disease diagnosis, risk assessment, and tailored therapeutic interventions.
Keywords: Cytokines; Gingival crevicular fluid; Inflammation; Interleukin-10; Interleukin-12; Interleukin-18; Periodontal disease.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Meteorin-like levels of oral fluids in periodontal health and diseases: a comparative cross-sectional study.Clin Oral Investig. 2025 Feb 18;29(2):137. doi: 10.1007/s00784-025-06222-7. Clin Oral Investig. 2025. PMID: 39964474 Free PMC article.
-
Interleukin-6, -17, and -35 levels in association with clinical status in stage III and stage IV periodontitis: a cross-sectional study.BMC Oral Health. 2024 Aug 30;24(1):1015. doi: 10.1186/s12903-024-04751-3. BMC Oral Health. 2024. PMID: 39215253 Free PMC article.
-
Evaluation of IL-1β, IL-1ra, and IL-10 levels and outcome of periodontal therapy in chronic periodontitis with familial Mediterranean fever.Clin Oral Investig. 2017 Jan;21(1):469-475. doi: 10.1007/s00784-016-1816-1. Epub 2016 Apr 11. Clin Oral Investig. 2017. PMID: 27068409
-
Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis.Odontology. 2012 Jul;100(2):215-21. doi: 10.1007/s10266-011-0042-1. Epub 2011 Sep 20. Odontology. 2012. PMID: 21932007
-
Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment.J Periodontol. 2000 Oct;71(10):1535-45. doi: 10.1902/jop.2000.71.10.1535. J Periodontol. 2000. PMID: 11063385
Cited by
-
Effects of non-surgical periodontal therapy on gingival crevicular fluid CTRP-1, TNF-α, and IL-10 levels.Clin Oral Investig. 2025 Jun 21;29(7):345. doi: 10.1007/s00784-025-06420-3. Clin Oral Investig. 2025. PMID: 40542868 Free PMC article.
-
The Role of Caspase-1 and Caspase-4 in Modulating Gingival Epithelial Cell Responses to Aggregatibacter actinomycetemcomitans Infection.Pathogens. 2025 Mar 18;14(3):295. doi: 10.3390/pathogens14030295. Pathogens. 2025. PMID: 40137780 Free PMC article.
References
-
- Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, Mealey BL, Papapanou PN, Sanz M, Tonetti MS (2018) A new classification scheme for periodontal and peri-implant diseases and conditions - introduction and key changes from the 1999 classification. J Clin Periodontol 45(Suppl 20):S1–s8. 10.1111/jcpe.12935 10.1111/jcpe.12935 - DOI - PubMed
-
- Grant MM, Taylor JJ, Jaedicke K, Creese A, Gowland C, Burke B, Doudin K, Patel U, Weston P, Milward M, Bissett SM, Cooper HJ, Kooijman G, Rmaile A, de Jager M, Preshaw PM, Chapple ILC (2022) Discovery, validation, and diagnostic ability of multiple protein-based biomarkers in saliva and gingival crevicular fluid to distinguish between health and periodontal diseases. J Clin Periodontol 49:622–632. 10.1111/jcpe.13630 10.1111/jcpe.13630 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous